This Edition
ARTICLE | Clinical News
ESBA105: Phase IIa started
WIR Staff
March 2, 2009 8:00 AM UTC
ESBATech began an open-label, German Phase IIa trial to evaluate topical ESBA105 in 25 patients. ...